Skip to main content

Table 1 IC50 outcomes for compounds 2a and 2b in A549, DLD-1, and L929 cell lines

From: Synthesis of new two 1,2-disubstituted benzimidazole compounds: their in vitro anticancer and in silico molecular docking studies

Compounds

IC50 (µM)

A549

DLD-1

L929

2a

111.70 ± 6.22

185.30 ± 5.87

167.30 ± 4.79

2b

176.80 ± 4.66

> 300

> 300

Cisplatin

9.79 ± 0.91

55.58 ± 4.05

7.41 ± 0.47

Back to article page

BMC Chemistry

ISSN: 2661-801X

Contact us